Guobang Pharma Ltd.SSE: 605507

Announcement on Wholly-owned Subsidiary Participating in Equity Investment Fund

· Issued by Guobang Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · · 9 pages · Chinese

Summary by 6ix AI

Guobang Pharma Ltd. announced that its wholly-owned subsidiary will participate in an equity investment fund, contributing a significant amount as a limited partner. The fund aims to invest in high-end pharmaceutical manufacturing, innovative drug industries, and other health-related sectors. This investment does not require board or shareholder approval and is not classified as a related party transaction or major asset restructuring. The company emphasizes that the investment carries risks due to its long investment cycle and low liquidity.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Wholly-owned Subsidiary Participating in Equity Investment Fund

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Guobang Pharma Ltd. on 6ix

Earlier from Guobang Pharma

Later from Guobang Pharma

All Guobang Pharma news releases